Rankings
▼
Calendar
TLSI Q4 2021 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
Q4 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$3M
Gross Profit
$3M
98.7% margin
Operating Income
-$6M
-247.0% margin
Net Income
-$7M
-271.3% margin
EPS (Diluted)
$0.09
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$680,921
Free Cash Flow
-$680,920
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$38M
Total Liabilities
$7M
Stockholders' Equity
$31M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$0
—
Gross Profit
$3M
$0
—
Operating Income
-$6M
-$108,493
-5740.9%
Net Income
-$7M
-$105,195
-6517.2%
← FY 2021
All Quarters
Q1 2022 →